JP2011522553A5 - - Google Patents

Download PDF

Info

Publication number
JP2011522553A5
JP2011522553A5 JP2011512983A JP2011512983A JP2011522553A5 JP 2011522553 A5 JP2011522553 A5 JP 2011522553A5 JP 2011512983 A JP2011512983 A JP 2011512983A JP 2011512983 A JP2011512983 A JP 2011512983A JP 2011522553 A5 JP2011522553 A5 JP 2011522553A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
growth factor
interleukin
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011512983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011522553A (ja
JP5632833B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/057232 external-priority patent/WO2009150199A1/en
Publication of JP2011522553A publication Critical patent/JP2011522553A/ja
Publication of JP2011522553A5 publication Critical patent/JP2011522553A5/ja
Application granted granted Critical
Publication of JP5632833B2 publication Critical patent/JP5632833B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011512983A 2008-06-11 2009-06-11 肝臓前駆細胞の馴化培地 Active JP5632833B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08010651 2008-06-11
EP08010651.1 2008-06-11
PCT/EP2009/057232 WO2009150199A1 (en) 2008-06-11 2009-06-11 Conditioned medium of liver progenitor cells

Publications (3)

Publication Number Publication Date
JP2011522553A JP2011522553A (ja) 2011-08-04
JP2011522553A5 true JP2011522553A5 (enExample) 2012-07-12
JP5632833B2 JP5632833B2 (ja) 2014-11-26

Family

ID=40905279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011512983A Active JP5632833B2 (ja) 2008-06-11 2009-06-11 肝臓前駆細胞の馴化培地

Country Status (12)

Country Link
US (2) US10456425B2 (enExample)
EP (1) EP2296672B1 (enExample)
JP (1) JP5632833B2 (enExample)
CN (2) CN102119031B (enExample)
BR (1) BRPI0909866B1 (enExample)
CA (1) CA2727392C (enExample)
DK (1) DK2296672T3 (enExample)
ES (1) ES2556630T3 (enExample)
HU (1) HUE028676T2 (enExample)
PL (1) PL2296672T3 (enExample)
PT (1) PT2296672E (enExample)
WO (1) WO2009150199A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2333047A1 (en) * 2009-12-09 2011-06-15 Fresenius Medical Care Deutschland GmbH Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease
US8603470B1 (en) * 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
DK3016665T3 (da) 2013-07-05 2019-11-25 Univ Catholique Louvain Konditioneret medium fra humane voksne leverstamceller og dets anvendelse i behandlingen af leverlidelser
BR112016004911A2 (pt) 2013-09-05 2017-09-05 Inis Biotech Llc Proteína secretada, acídica e rica em cisteína, um novo alvo para o tratamento e prevenção de insuficiência aguda do fígado
RU2644650C2 (ru) * 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
CN104818245B (zh) * 2015-05-29 2020-02-04 广州赛莱拉干细胞科技股份有限公司 一种肝脏干细胞的培养基及培养方法
AU2017217688B2 (en) 2016-02-10 2023-01-19 Wake Forest University Health Sciences Model system of liver fibrosis and method of making and using the same
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
US20200087390A1 (en) 2016-12-21 2020-03-19 Amgen Inc. Anti-tnf alpha antibody formulations
EP3801028A4 (en) 2018-05-30 2022-04-13 Direct Biologics LLC A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use
CN109628377A (zh) * 2019-01-02 2019-04-16 贵州省人民医院 一种小鼠原代肝细胞灌注式分离及离体培养方法
CN111607556B (zh) 2019-01-25 2022-06-07 中国科学院广州生物医药与健康研究院 一种培养扩增人肝祖细胞的培养基及其应用
EP3920946A4 (en) 2019-02-07 2022-11-09 Direct Biologics LLC METHOD FOR TREATING OSTEOARTHRITIS USING A COMBINATION OF EXOSOMES OF MESENCHYMATE STEM CELLS, SYNOVIAL MESENCHYMATE STEM CELLS AND SCAFFOLDS
CN113939585A (zh) * 2019-04-30 2022-01-14 普罗米瑟拉疗法公司 人同种异体肝源性祖细胞的制备
CN111394391B (zh) * 2019-07-11 2022-12-06 上海赛立维生物科技有限公司 肝祖细胞样细胞库的构建方法及其制备的细胞株与应用
CA3146433A1 (en) 2019-07-18 2021-01-21 Direct Biologics Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
KR20230004709A (ko) 2020-04-22 2023-01-06 다이렉트 바이오로직스 엘엘씨 감염성 질환과 연관된 염증성 병태를 치료하기 위한 방법 및 조성물
WO2025226276A1 (en) 2024-04-25 2025-10-30 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH093099A (ja) * 1995-06-20 1997-01-07 Toyobo Co Ltd マクロファージ刺激蛋白質改変体およびその製造法
US6475490B1 (en) * 1998-10-19 2002-11-05 Fordham University Compositions and methods for promoting tissue repair using heat shock proteins
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6719969B1 (en) * 1999-08-09 2004-04-13 The Regents Of The University Of Michigan Treatment of liver disease and injury with CXC chemokines
CA2290240C (en) * 1999-11-24 2008-03-11 Stergios Stergiopoulos High resolution 3d ultrasound imaging system deploying a multi-dimensional array of sensors and method for multi-dimensional beamforming sensor signals
US7547674B2 (en) * 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US6916770B2 (en) 2001-04-27 2005-07-12 Polyone Corporation Multi-functional color concentrate compositions
CA2452865A1 (en) * 2001-06-07 2002-12-12 Skinmedica, Inc. Conditioned cell culture media and uses thereof
WO2003033697A1 (en) * 2001-10-18 2003-04-24 Ixion Biotechnology, Inc. Conversion of liver stem and progenitor cells to pancreatic functional cells
WO2006126219A1 (en) 2005-05-26 2006-11-30 Fresenius Medical Care Deutschland G.M.B.H. Liver progenitor cells
JP2009527475A (ja) * 2006-02-16 2009-07-30 バーンハム インスティトゥート フォー メディカル リサーチ ヒト胚性幹細胞又は他の前駆細胞により馴化された培地、及びその使用
CN103893211A (zh) * 2006-03-07 2014-07-02 吉塔·什罗夫 包含人胚胎干细胞和其衍生物的组合物、其使用方法和制备方法
FR2912916B1 (fr) * 2007-02-26 2009-05-22 Oreal Composition cosmetique ou dermatologique comprenant un milieu de culture cellulaire

Similar Documents

Publication Publication Date Title
ES2928670T3 (es) Formulación que contiene virus y utilización de la misma
ES2583371T3 (es) Composiciones, métodos, y dispositivos para tratar enfermedades hepáticas
US20210008106A1 (en) Mitochondrial treatment of organs for transplantation
Johansson et al. Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate
Liu et al. Study on therapeutic action of bone marrow derived mesenchymal stem cell combined with vitamin E against acute kidney injury in rats
JP2023017017A (ja) 上皮間葉転換を予防または最小限にする方法及び組成物
CN110177872A (zh) 间充质干细胞和药物组合物
JP2023537204A (ja) 間葉系ストローマ細胞由来の細胞外小胞(ev)および前記evを得るための方法
CN107114356A (zh) 一种胎盘及脐带细胞保护液
JP2023520233A5 (enExample)
ES2966620T3 (es) Preparación de células progenitoras hepáticas alogénicas humanas
CN105377275A (zh) 用于静脉给药的干细胞组合物
TW202100170A (zh) 用於治療慢性肝衰竭之急性發作的成人肝先驅細胞
TW202035682A (zh) 表現hla-g之肝先驅細胞及取得包含該等細胞之此等細胞組成物之方法與其用途
EP3947645A1 (en) Adult liver progenitor cells for treating non-alcoholic fatty liver disease
WO2023077160A1 (en) Methods of treating diseases associated with cellular-energy deficiency or mitochondrial dysfunction by locoregional delivery of extracellular vesicles that have a cargo with an enhanced bioenergetic profile
EP3923965A1 (en) Methods and compositions for treating viral infections and sequelae thereof
CN107980767B (zh) 一种长期保存过表达ang-1的epc的保存液
Zhou et al. ROS-responsive diselenide exosomes restores mitophagy to resolve sterile inflammation in liver IRI
CN105532646A (zh) 肝细胞保存液及其制备方法和应用
EP2175718B1 (en) Body fluid expanders comprising n-substituted aminosulfonic acid buffers
CN106474157B (zh) 一种肝干细胞注射液及其制备方法
CN103301118A (zh) 注射用精氨酸布洛芬组合物
US20220049225A1 (en) Cell composition comprising liver progenitor cells expressing hla-e
CN116510013A (zh) 一种靶向血管治疗肝纤维化的药物组合物及应用方法